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Edited by Vladimir SkulachevAbstract The impact of cAMP on ROS-balance in human and
mammalian cell cultures was studied. cAMP reduced accumula-
tion of ROS induced by serum-limitation, under conditions in
which there was no signiﬁcant change in the activity of scavenger
systems. This eﬀect was associated with cAMP-dependent acti-
vation of the NADH-ubiquinone oxidoreductase activity of com-
plex I. In ﬁbroblasts from a patient a genetic defect in the
75 kDa FeS-protein subunit of complex I resulted in inhibition
of the activity of the complex and enhanced ROS production,
which were reversed by cAMP. A missense genetic defect in
the NDUFS4 subunit, putative substrate of PKA, suppressed,
on the other hand, the activity of the complex and prevented
ROS production.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The life of mammals depends on the free energy made avail-
able through cellular oxidation of food-stuﬀs by oxygen. In
mitochondria the redox enzymes of the respiratory chain are
organised in the inner membrane so as to oxidise reduced nic-
otinamide nucleotides and ﬂavin coenzymes, in a stepwise pro-
cess, with ﬁnal reduction of O2 to H2O and conservation of
free energy as a transmembrane electrochemical proton gradi-
ent, utilised to drive ATP synthesis from ADP and Pi [1]. In
addition to reduction to H2O, some oxygen can be partially re-
duced to reactive oxygen (ROS) [2]. Cellular ROS production,
which generally accounts for about 1–2% of the overall cellular
oxygen consumption, under certain pathophysiological condi-
tions can increase signiﬁcantly. ROS are involved in cell signal-
ling [2]. Oxidative stress, resulting from disturbed free-radical
and cellular redox balance, is associated with ageing and sev-
eral human diseases [2].
Mitochondria are quantitatively the primary source of
ROS [3]. Oxygen superoxide ðO2 Þ is produced in the mito-
chondrial matrix by complex I (NADH ubiquinone oxido-
reductase) [3] and complex III (ubiquinone cytochrome*Corresponding author. Present address: Department of Medical
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doi:10.1016/j.febslet.2006.06.085c oxidoreductase) [4]. The latter also produces O2 in the
intermembrane mitochondrial space [4]. Complex IV (cyto-
chrome c oxidase), due to its high catalytic capacity of O2
reduction to H2O, does not produce ROS, rather prevents
their formation by keeping the cellular oxygen concentration
low [5]. ROS can also be generated in other cell compart-
ments by diﬀerent systems; among these the family of plasma
membrane NADPH oxidases, which are involved in cell sig-
nalling [2]. O2 , which with a pK around 5.0 exists at physi-
ological pH essentially in the membrane impermeable anionic
form, is converted by superoxide dismutases to H2O2. H2O2
diﬀuses across cellular membranes and can be neutralised
by a set of endogenous scavenger systems [2,6] as well as
by nutritional antioxidants.
cAMP, produced by the plasma membrane adenylyl cyclase
in response to hormones and neurotransmitters [7] and by the
bicarbonate-activated soluble adenylyl cyclase, localised to
the nucleus, mitochondria and other intracellular structures
[8], plays a central regulatory role in energy-supplying and
energy-requiring processes. cAMP dependent protein kinase
(PKA), which is present in diﬀerent subcellular compart-
ments, including mitochondria [9], activates the utilisation
of glycogen and lipid energy stores as well as energy-requiring
processes, like cell growth and development, neuronal activ-
ity, etc. [7]. It has recently been found that activation of
the cAMP cascade reverts accumulation of H2O2 and depres-
sion of the activity of complex I observed in serum-limited
cell cultures [10]. Here, we show that activation of complex
I and prevention of reactive oxygen species accumulation
by cAMP is a general phenomenon observed in a variety of
mammalian and human cell cultures under diﬀerent patho-
physiological conditions.2. Materials and methods
2.1. Cell culture and mitoplast preparation
Neonatal normal human dermal ﬁbroblasts (NHDF-neo, Camb-
rex# CC-2509), Hela (ATCC# CCL-2), Rabdomiosarcoma cells
(RD, ATCC# CCL-136), Hepatoma cells (HepG2, ATCC# HB-
8065), Balb/c 3T3 (ATCC# CCL-163), NIH 3T3 (ATCC# CRL-
1658) and ﬁbroblasts from the patients with NDUFS1 and NDUFS4
mutations were grown in the exponential phase in high glucose Dul-
becco’s modiﬁed Eagle’s medium (DMEM, EuroClone) supple-
mented with 10% fetal bovine or calf serum, plus 2 mM glutamine
(Euroclone), 100 IU/ml penicillin (Euroclone) and 100 IU/ml strepto-
mycin (Euroclone). Further conditions are speciﬁed in the legends to
ﬁgures. Fibroblasts harvested and mitoplast preparation as described
in [20].blished by Elsevier B.V. All rights reserved.
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DNA ladder detection was performed by the Roche kit. For the
CFDA (6-carboxyﬂuorescein diacetate)/annexin V–Cy3 apoptotic as-
say the LSCM analysis was performed according to the manufacturer
(Sigma). Live cells label only with the intracellular-esterase-deacety-
lated CFDA (carboxyﬂuorescein (6-CF), green ﬂuorescence), whereas
cells in the early stage of apoptosis spot with both annexin V–Cy3
(red) and 6-CF. The quiescence-state of serum-limited cells was veriﬁed
by propidium iodide-based cytoﬂuorimetry.2.3. Laser scanning confocal microscopy analysis (LSCM)
Cells were seeded onto ﬁbronectin coated glass bottom dishes. After
adhesion, living cells were incubated for 20 min at 37 C with: Mito-
Capture (Biovision, 1/1000 dilution) to monitor mitochondrial mem-
brane potential; 10 lM dichloroﬂuorescein-diacetate DCF-DA
(Oregon Probes) or 3 lM MitoSOX (Oregon Probes) for detection of
H2O2 and O

2 respectively. Stained cells were washed with PBS and
examined by a Nikon TE 2000 microscope (images collected using a
60· objective (1.4 NA)) coupled to a Radiance 2100 dual laser (four-
lines Argon–Krypton, single-line Helium–Neon) scanning confocal
microscopy system (Biorad). The ﬂuorescent signal of the MitoCapture
double-emitter probe was examined sequentially, exciting ﬁrst with theFig. 1. Cellular ROS pattern in human and murine cell cultures. (A) Apop
were grown in the exponential phase (a) (10% fetal bovine serum in DMEM)
(0.5% FBS in DMEM) (b) or 2 h treatment with 500 lM H2O2 (apoptosis
intracellular esterase-deacetylated 6-carboxy ﬂuorescein diacetate (CFDA),
ﬂuorescence of annexinV–Cy3. Bars: 20 lm. (B) NHDF-neo assayed by lase
detected by the red-ﬂuorescence of the positively charged Mitocapture dye
(DCF-DA), O2 by the red-ﬂuorescence of the MitoSOX dye. Where indicate
cAMP (c). LSCM images of the serum-limited cells (b) are given at low and h
and O2 levels in NHDF-neo, Hela cells, murine ﬁbroblasts (Balb/C 3T3 and
For details see Section 2.Ar–Kr laser beam (kex = 488 nm) and then with the He–Ne laser beam
(kex = 543 nm). The green ﬂuorescence of DCF was analysed by excit-
ing the sample with the Ar–Kr laser beam (kex = 488 nm). Confocal
planes of 0.2 lm in thickness were examined along the z-axis, from
the top to the bottom of the cells. Acquisition, storage and analysis
of data were made by using LaserSharp and LaserPix Biorad software.
2.4. Measurement of glutathione and glucose-6-phosphate
Cells were suspended in PBS and homogenized. After protein precip-
itation with 2% sulfosalycilic acid, total glutathione was determined in
the supernatant as in [10]. For measurement of reduced glutathione
(GSH), proteins were precipitated with 10% perchloric acid (PCA)
and the supernatant analysed by HPLC. Glucose-6-phosphate was
determined as in [25].
2.5. Determination of the activity of ROS scavenger enzymes
Aliquots of sonicated cell suspension, were used for spectrophoto-
metric measurement of glucose-6-phosphate dehydrogenase (G6PDH)
[26], GSSG reductase, GSH peroxidase and catalase [27]. The Super-
oxide dismutase activity was determined with the Calbiochem assay
kit. The Mn-SOD activity represented the residual activity after inhibi-
tion of Cu/Zn-SOD with 0.2 mM phenylglyoxal.tosis assays. Neonatal normal human dermal ﬁbroblasts (NHDF-neo)
, followed, where indicated, by 48 h cultivation under serum-limitation
-induction) (d). Live cells were detected by the green ﬂuorescence of
apoptotic cells were detected by DNA fragmentation and the red-
r scanning confocal microscopy (LSCM) for: mitochondrial potential
, H2O2 by the green ﬂuorescence of 2
0,7 0-dichloroﬂuorescin diacetate
d, serum-limited cell cultures (b) were incubated with 100 lM dibutyryl
igh magniﬁcation. Bars: 20 lm. (C) Semi-quantitative analysis of H2O2
NIH 3T3), rabdomiosarcoma cells (RD) and hepatoma cells (HepG2).
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Mitoplasts were exposed to ultrasound energy for 15 s at 0 C and
the Vmax of NADH–UQ oxidoreductase activity was measured as de-
scribed in [20]. Cytochrome c oxidase activity was measured as in [20].3. Results and discussion
3.1. Serum-limitation in cultured cell lines induces mitochondrial
ROS production which is abrogated by cAMP
Diﬀerent human and murine cell lines were analysed, either
in their exponential growth phase (serum-saturated), or when
brought in a quiescent state by 48 h cultivation under serum-
limitation. This period of serum limitation did not impair cell
viability nor produced signs of apoptosis (Fig. 1A) or impair-
ment of the mitochondrial potential (Fig. 1B). In the serum-
limited cells there was, however, a large accumulation of
H2O2 as compared to the serum-saturated cells which showed
little, if any H2O2 (Fig. 1B, see also [10]). H2O2 was localised inFig. 2. Pattern of ROS scavenger systems in human and murine cell cult
glutathione (GSH), glucose-6-phosphate (G6P), activity of glucose-6-phospha
peroxidase-1 (GPX-1), catalase, Cu/Zn-superoxide dismutase (Cu/Zn SOD)
neo, Hela cells and Balb/C 3T3 grown in the exponential phase (a), under 4
60 min treatment with 100 lM dibutyryl cAMP. For details see Section 2.spots with a cellular distribution similar to that of mitochon-
dria. Serum-limited cells showed, also, a large accumulation
of O2 in the mitochondrial matrix. Exposure (60 min) of ser-
um-limited cell cultures to dibutyryl cAMP, a permeant deriv-
ative of cAMP, resulted in the disappearance of H2O2 from
cells and O2 from mitochondria, reproducing the situation ob-
served in the serum-saturated cells (Fig. 1B). Semi-quantitative
analysis showed that the increase in the level of H2O2 and O

2 ,
observed in serum-limited cells, and their disappearance upon
cAMP treatment is a general phenomenon, observed in six dif-
ferent lines of tested human and murine cells (Fig. 1C). It was
previously found that addition to cell cultures of DPI, inhibi-
tor of plasma membrane NADPH oxidase, or of allopurinol,
inhibitor of xanthine oxidase, did not prevent accumulation
of ROS in serum-limited cells. H89, a speciﬁc inhibitor of
cAMP-dependent protein kinase (PKA) depressed, on the
other hand, the ROS-removing eﬀect of cAMP [10]. Thus the
cyclic eﬀect of the nucleotide involves PKA.ures. Total cellular content of glutathione (GSH + GSSG), reduced
te dehydrogenase (G6PDH), glutathione reductase (GR), glutathione-
and Mn-superoxidedismutase (Mn SOD) were determined in NHDF-
8 h serum-limitation (b) and under 48 h serum-limitation followed by
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with depression of ROS-scavenger enzymes
RT-PCR analysis has shown some depression in the tran-
script levels of ROS scavenger enzymes in serum starved Hela
cells [10]. We have now carried out a systematic study of the
impact of serum-limitation and cAMP on the levels of total
and reduced glutathione, and the functional activity of scaven-
ger enzymes in three diﬀerent cell lines. Serum-limitation had
no eﬀect on the total glutathione cellular content, except Hela
cells which showed a signiﬁcant decrease. The accumulation of
ROS was associated with an extensive oxidation of glutathi-
one, which was not reversed upon subsequent treatment of
the three cell lines with cAMP (Fig. 2). Serum-limitation and
subsequent treatment with cAMP had no signiﬁcant eﬀect on
the level of glucose-6-phosphate and glucose-6-phosphate
dehydrogenase activity, a major producer of NADPH, which
is utilised by glutathione reductase (Fig. 2) [11]. Also, no sig-
niﬁcant change was produced by serum-limitation and cAMP
treatment in the activity of glutathione reductase, glutathione
peroxidase and catalase. Thus the ROS accumulation induced
by serum-limitation and the ROS – removing eﬀect of cAMP
were not due to depression and reactivation of these scavenger
systems respectively. They appear, rather, to be associated with
modulation of ROS production.
The distribution of ROS in/around mitochondria shows the
primary role of mitochondrial redox enzymes in their produc-
tion. In keeping with this, it was found that whilst the activity
of the cytosolic Cu/Zn-SOD did not show any change, the
mitochondrial Mn-SOD increased in the serum-limited cells,
with the exception of Hela cells. The expression of Mn-SOD
has been shown to be up-regulated by oxidative stress [12]
and in patients with complex I deﬁciency, which also present
increased ROS levels [13]. No signiﬁcant further change in
the activity of Mn-SOD of serum-limited cells was induced
by cAMP (Fig. 2).Fig. 3. Complex I and complex IV activities in human and murine cell cultur
IV activities represent the means ± S.E.M. of three or more determinations in
and ﬁbroblasts from human patients with mutations in the NDUFS1 and ND
(means of three determinations) in patient’s ﬁbroblasts, using the DCF ﬂuore
(a), (b) and (c) see legend to Fig. 2; c 0 refers to NDUFS1 mutant ﬁbroblasts g
for 60 min.3.3. cAMP-abrogation of ROS production correlates with
re-activation of mitochondrial complex I
Analysis of the impact of cell serum-limitation and cAMP
on the activity of complex I in the mitoplast fraction revealed
an inverse relationship between the observed changes in cellu-
lar ROS and the forward NADH-ubiquinone oxido-reductase
activity of the complex. In the three cell lines tested, serum-
limitation was associated with depression of the Vmax of the
NADH-ubiquinone oxido-reductase activity, which was lar-
gely rescued by the addition of dibutyryl-cAMP (see also
[10]) (Fig. 3). In other cell lines, like mouse C2C12 myoblasts,
cAMP stimulation of complex I activity was also observed in
the exponential growth phase [9]. No signiﬁcant changes in
the activity of complex IV were, on the other hand, produced
by serum-limitation of cell growth and subsequent treatment
with cAMP (Fig. 3).
Genetic deﬁciency in the activity of complex I represents the
most frequent cause of inborn mitochondrial disease [14]. In
two cases of autosomal recessive genetic defects of complex
I, in children aﬀected by fatal neurological disorder, we have
investigated the pathogenic mechanism. One, consisting of a
non-sense G44A mutation in the nuclear NDUFS4 gene-cod-
ing for a 18 kDa subunit (the complex is constituted by 46 sub-
units; see Ref. [15]), was associated with defective assembly
and suppression of the NADH ubiquinone oxidoreductase
activity of the complex [16,17]. The other, C1564A mutation
in the nuclear NDUFS1 gene (Gln 522 Lys replacement) cod-
ing for a 75 kDa FeS subunit, was associated with severe but
not complete depression of the NADH ubiquinone oxidore-
ductase activity (Fig. 3) [18]. In the ﬁbroblasts of the patient
with the NDUFS4 mutation, H2O2 and O

2 levels were very
low. In the NDUFS1 mutant cells large levels of H2O2 and
O2 were detected. The depression of complex I activity and
the accumulation of ROS observed in the NDUFS1 mutant
cells were largely reversed by cAMP (Fig. 3A and B; cf. Ref.es and ROS levels in patient’s ﬁbroblasts. (A). Complex I and complex
mitoplasts from human (NHDF-neo, Hela cells), murine (Balb/c 3T3)
UFS4 genes respectively. (B). Semi-quantitative analysis of H2O2 levels
scent probe as described in Fig. 1C. For the experimental conditions in
rown in the exponential phase and exposed to 100 lM dibutyryl-cAMP
C. Piccoli et al. / FEBS Letters 580 (2006) 4539–4543 4543[18]). In the case of the NDUFS1-mutation, the inhibition of
the NADH-ubiquinone oxidoreductase can be attributed to al-
tered function of the 75 kDa Fe–S protein encoded by this
gene. The Gln 522 Lys substitution can promote direct oxida-
tion by molecular oxygen of the Fe-S center of this subunit,
once reduced by the electrons delivered to the enzyme by
NADH (see also [19]).
All the above shows that the changes in the cellular ROS
balance in mammalian cells, observed in the physio-patholog-
ical conditions examined, are correlated with modulation/
defect of the redox activity of complex I.
The reduction of ROS level and activation of complex I pro-
moted by cAMP involve post-translational protein phosphor-
ylation. The cAMP eﬀects can be directly associated with
phosphorylation of complex I subunits [9,20–22] and or
PKA-mediated changes in the redox [23]/nitrosylation [24]
state of complex I subunits.
The cAMP eﬀects described here can play a general role in
the physiological control of free-radical balance and the course
of oxidative stress-associated human pathophysiology.
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